Chargement en cours...
The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
Febuxostat (FBX) is a drug able to inhibit xanthine oxidase and reduce uric acid production commonly used for the treatment of hyperuricemia in subjects suffering from gout. Several studies have also been directed at its use as anti-cancer drug during the last years, opening a window for its off-lab...
Enregistré dans:
| Publié dans: | Pharmaceutics |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7600960/ https://ncbi.nlm.nih.gov/pubmed/33050567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12100956 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|